Log In
Thursday 22nd March 2018

Drug groups urged to lower NHS prices

7th October 2008

The government is putting pressure on pharmaceutical companies to provide new medication at lower cost, with the idea that the health service would pay more if the drug proves to have significant benefits to patients.

The government sees the scheme as a way of coping with the top-up payment issue, where patients could pay to top-up their own treatments with medication which the National Institute for Health and Clinical Excellence had said was "clinically effective" but had not approved for NHS treatment.


Share this page


There are no comments for this article, be the first to comment!

Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

M3 - For secure managed hosting over N3 or internet
© Mayden Foundation 2018